pesaro 13 settembre 2014 utilizzo in spect e pet › congressi › burroni... · 2014-09-22 ·...
TRANSCRIPT
![Page 1: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/1.jpg)
Protocolli d’Impiego e Risultati Clinici
Maria Luisa De Rimini UOD Cardiologia Nucleare
AORN Ospedali dei Colli - Monaldi
Napoli
Utilizzo in SPECT e PET Pesaro
13 Settembre 2014
![Page 2: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/2.jpg)
![Page 3: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/3.jpg)
Rapiscan agonista selettivo A2A
Receptor
Subtype Response to an Agonist
A1 Slows AV / SA Nodal Conduction
A2A
Coronary Vasodlation
Sympathetic excitation
A2B Mast Cell Degranulation
A3 Bronchoconstriction ? Preconditioning?
Methylxanthines (caffeine, aminophyline) block adenosine receptors
Adenosine
Cell Membrane
Adenosine Regadenoson
A2A
Increase myocardial blood flow by 2 to 4-fold
Regadenoson was approved for clinical use in Europe in 2011
![Page 4: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/4.jpg)
FDA Issues Warning on Regadenoson and Adenosine : pts with Unstable Angina
J Nucl Med. 2014;55:12N
![Page 5: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/5.jpg)
Coronary Blood Flow J Nucl Cardiol 2007;14:514-520
Pilot Myocardial
Perfusion Imaging J Am Coll Cardiol.2005 6;46:2069-75
Caffeine Interaction J Am Coll Cardiol 2008;51:328-329
Asthma Safety J Nucl Cardiol 2008;15(3):329-36
COPD Safety J Nucl Cardiol 2008;15(3):319-28
Sub-maximal Exercise Safety J Nuclear Cardiol 2009; 65(16):63–72
ADVANCE MPI Trials*
Two randomised, double blind
studies in patients undergoing stress
myocardial perfusion imaging
J Nucl Cardiol 2007;14:645-658 J Am Coll Cardiol 2008;1:307-316
J Am Coll Cardiol Img 2009;2:959–68
Healthy Volunteer
Safety Study Gordi T Clin Pharmacokinet
2006;45:1201-1212
Renal Impairment J Clin Pharmacol 2007;47:825-833
Phase 1 Phase 2 Phase 3
* ADenosine Versus RegAdeNoson Comparative Evaluation for Myocardial Perfusion Imaging
Asthma / COPD J Nucl Cardiol 2012 Aug;19(4):681-92
Renal Impairment J Nucl Cardiol 2012 Apr;19(2):319-29
Caffeine J Nucl Cardiol 2011;18:759
Post - approval
![Page 6: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/6.jpg)
Regadenoson-induced coronary hyperemia
Intr
aco
ron
ary
AP
V R
atio
Time (min)
Lieu HD et al. J Nucl Cardiol 2007;14:514-520
rapid onset of action
Rapiscan effect on CBF
![Page 7: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/7.jpg)
![Page 8: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/8.jpg)
ADVANCE MPI 2 (Adenosine vs. Regadenoson Comparative Evaluation for Myocardial Perfusion Imaging
Double-blind, randomized trial comparing image results in patients undergoing standard gated adenosine SPECT MPI who were then randomized in a 2:1 ratio to either regadenoson (N = 495) or a second adenosine SPECT (N = 260)
JJ Mahmarian et al JACC CI.2009
Total Perfusion Defect Size Relationship between the adenosine and regadenoson induced perfusion defect size (PDS)
![Page 9: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/9.jpg)
ADVANCE MPI 2 (Adenosine vs. Regadenoson Comparative Evaluation for Myocardial Perfusion Imaging
Double-blind, randomized trial comparing image results in patients undergoing standard gated adenosine SPECT MPI who were then randomized in a 2:1 ratio to either regadenoson (N = 495) or a second adenosine SPECT (N = 260)
JJ Mahmarian et al JACC CI.2009
Ischaemic Defect Size Relationship between the adenosine and regadenoson induced perfusion defect size (PDS)
PD
S R
ega
de
no
son
PDS Adenosine
![Page 10: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/10.jpg)
Side Effect Profile
AR with an incidence ≥ 5%
Iskandrian JNC 2007; 14:645
Cerqueira JACC Img 2008; 1: 307
![Page 11: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/11.jpg)
![Page 12: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/12.jpg)
N=1764 patients
Regadenoson in Europe: First- year experience of regadenoson stress
combined with submaximal exercise inpatients undergoing myocardial
perfusion scintigraphy Brinkert M, Reyes E, Underwood SR et al. Royal Brompton Hospital, London, UK 2013 under review
![Page 13: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/13.jpg)
Cabrera R, et al. JNC February 2013 HR change SBP change DBP change
Bp
m/m
mH
g
Reg alone
Reg walk
P=0.001
Regadenoson + low-level exercise
n =887
n =485
Protocol
![Page 14: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/14.jpg)
Cabrera R, et al. JNC February 2013
Variable (%) Reg alone Reg Walk P value
Chest pain 20 16 0.05
Flushing 14 10 0.02
Dizziness 5 10 0.001
Abdominal symptoms 21 12 0.001
Dyspnoea 54 56 0.4
Aminophylline use 11 6 0.001
P=0.47
P=0.006
Reg alone
Reg walk
%
![Page 15: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/15.jpg)
Conclusion Among patients undergoing standard treadmill stress testing for MPI who do not reach THR, the administration of Reg at peak exercise is safe and without major adverse events. Future large prospective studies are warranted to further evaluate the off-label use of Reg in this setting.
![Page 16: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/16.jpg)
Wael A, et al. Eur J Nucl Med Mol Imaging 2013;40:341
Exercise + Regadenoson
Reg. +++ Dyp - Ade -
![Page 17: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/17.jpg)
Wael A, et al. Eur J Nucl Med Mol Imaging 2013;40:341
Exercise + Regadenoson
combining Reg with standard symptom-limited treadmill stress test is an efficient alternative and provides not only exercise functional capacity but also a diagnostic MPI by
inducing maximal hyperemia at the time of tracer injection
![Page 18: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/18.jpg)
![Page 19: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/19.jpg)
J Nucl Cardiol 2008
![Page 20: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/20.jpg)
Circulation. 2014;130:350-379
Women capable of maximal exercise should have an exercise MPI, whereas those who are functionally incapable should undergo a pharmacological stress test with 1 of several vasodilator agents (ie, dipyridamole, adenosine, or regadenoson). When using Rb-82 or [13N]ammonia (N-13 ammonia) PET, absolute blood flow at rest and stress may be ascertained to provide
measurements of myocardial flow reserve.
![Page 21: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/21.jpg)
Diagnostic evaluation algorithm for women presenting with suspected ischemic heart
disease (IHD) symptoms and intermediate IHD risk and intermediate-high IHD risk.
Mieres J H et al. Circulation. 2014;130:350-379
Copyright © American Heart Association, Inc. All rights reserved.
![Page 22: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/22.jpg)
Pharmacological Stress Agent in MPI SPECT Studies with Radionuclides
Selective adenosine A2A receptor agonist
0 1 2 // 30 min
Radiotracer
Regadenoson (0.4 mg/5ml)
Saline injection (10-20 ml)
Monitor HR, BP and ECG
Single-dose, non-weight-adjusted (400mcg) Bolus
Radiopharmaceutical myocardial extraction directly proportional to CBF
Onset of action within 30 sec
Similar side effect profile to adenosine but better tolerability
![Page 23: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/23.jpg)
99mTc – Tetrofosmin Vasodilator/Basal
![Page 24: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/24.jpg)
Pre-Stent
Stent
82Rb PET Vasodilator/Basal
![Page 25: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/25.jpg)
• Risoluzione spaziale e temporale
• Quantizzazione assoluta MBF – CFR
•Correzione Attenuazione
• Imaging Ibrido Di Carli MF, Hachamovitch R. Circulation 2007; 115:1464–80
PET/CT 82Rb
PET-CT
![Page 26: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/26.jpg)
Bateman TM, et al. J Nucl Card 2006
PET vs SPECT: Higher Accuracy, Lower Radiation exposure
13 N-ammonia 82Rb 99mTcMibi/Tetr
Effetcive Dose (mSv) 0.74 – 2.48 2.5 – 4 10.7 - 16
Hardware: CdZnTe: Lower Dose
![Page 27: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/27.jpg)
RF N13-
Ammonio O-15 Rb-82
T½ 9.96’ 2’ 76’’
Att.
(MBq) 370 700-1500 1100-1500
Uso Perfus. Perfus. Perfus.
Vantaggi MBF MBF
•MBF
•Prodotto da
generatore
PET Cardiaca
EJNMMI Vol.32, No 7; 2005
Flusso (ml/m) / Perfusione
PET Differente cinetica di ciascun tracciante
![Page 28: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/28.jpg)
0
1
2
3
4
5
6
0 1 2 3 4 5 6
Absolute flow (ml/g/min)
Me
as
ure
d/m
od
elle
d f
low
82Rb
99mTc-MIBI MRI/CT contrast 18F-FBnTP
13N-ammonia 18F-Flurpiridaz
15O-water
PET o SPET con Quantizzazione? Differente cinetica di ciascun tracciante
EJNMMI Vol.32, No 7; 2005
![Page 29: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/29.jpg)
Quantitative PET: MBF N-13 Ammonia
![Page 30: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/30.jpg)
0 5 10 sec
20min – 60min
CT
Regadenoson 0.4 mg bolus
Flush N-13 Ammonia
Dynamic Stress PET
CT Scout
PET N-13 Ammonia
10 sec
N-13 Ammonia
Dynamic Basal PET
![Page 31: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/31.jpg)
0 5 10 15 20 25 30
CT-AC
CT Angio
mdc 82 Rb
Rest PET
CT-AC Stressor
82 Rb
Stress PET
CT Scout
82Rb Fast Protocol 35’ Rest / Dypiridamole
10 sec 10 sec
![Page 32: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/32.jpg)
0 5 10 15 20 25 30
CT-AC
82 Rb
Dynamic Basal PET
82 Rb
Dynamic Stress
PET
CT Scout
82Rb Fast Protocol 35’ Rest / Regadenoson
Regadenoson 0.4 mg bolus
10 sec 10 sec
Flush
![Page 33: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/33.jpg)
Stent: Culprit Lesion
MVD
![Page 34: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/34.jpg)
Phase Analisys
Vasodilator LVEF= 45% Basal LVEF = 48%
![Page 35: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/35.jpg)
Stent: CDx e CX
US: FE del VS = 45%
MSCT: St. multiple non occlusive
Diabete da 7 a., no insulina
Dispnea da moderato sforzo
![Page 36: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/36.jpg)
Prognostic Value
![Page 37: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/37.jpg)
• Summed Scores SSS; SRS; SDS
N Mild-Moder Severe
SDS < 3 3 - 8 > 8
SSS < 4 4 -13 > 13
• LVEF; RWM; RWT; Volume
Berman DS et al. Am J Cardiol 2000;86:1171-1175
• % Extension
![Page 38: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/38.jpg)
Path TID value: ≥1.18 men / ≥1.22 women
cCTA and SPECT MPI • Stress Test: 85% max HR • Pharmacologic Stress Test: Regadenoson 0.4 mg iv bolus Saline flush Radiotracer stress dose
20 sec
![Page 39: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/39.jpg)
![Page 40: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/40.jpg)
PET Summed Score di Perfusione e LVEF
Lertsburupa et al. JNC 2008
![Page 41: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/41.jpg)
Inclusion criteria were prospective studies, observational studies, retrospective studies, and case series published in peer-reviewed journals, involving humans; using either Rb-82 PET, or technetium (Tc)-99m SPECT 2006 – marzo 2012
![Page 42: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/42.jpg)
99mTc-Sestamibi stress G-SPECT: scan a 30’-45’: 82Rb PET:
Stress G-PET
•LVEF durante test iperemico
•LVEF post-stress (tardivo)
82Rb PET: migliore stima di patologia ischemica multivascolare o del Tr. Comune.
(Equilibrio Ischemico)
Joanne D Schuijf and Jeroen J Bax; Heart 2008;94;255-257
S. Dorbala et al. J Nucl Med 2007; 48:349–358
![Page 43: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/43.jpg)
AHA Scientific Statement. Circulation 2002
GSPECT: Valore Prognostico Incrementale LVEF (<45%) e ESV (>70ml) Post-Stress
Predittori Indipendenti di Morte Cardiaca
Sharir T. et al. Circulation 1999
![Page 44: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/44.jpg)
SSS < 4 (Equilibrio Ischemico)
TID vn 0.98-1.13
![Page 45: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/45.jpg)
AHA Scientific Statement. Circulation 2002
7% pz con MVD: Perfusione omogenea
Perfusione + LV EF: Definizione di equilibrio ischemico nel 100% pz
Stress 82Rb GPET
LVEF durante test iperemico
Lertsburapa et al. JNC 2008; 15:745-753
Prognosi
![Page 46: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/46.jpg)
J Nucl Cardiol February 2014, Volume 21 pp 4-16
![Page 47: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/47.jpg)
![Page 48: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/48.jpg)
Circulation. 2014;129:2518-2527
![Page 49: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/49.jpg)
CMD = CFR <2.0
• CFR: powerful incremental predictor of MACE (hazard ratio, 0.80 [95% confidence interval, 0.75–086] per 10% increase in CFR; P<0.0001)
• CFR: favorable net reclassification improvement (0.280 [95% confidence interval, 0.049–0.512]), after adjustment for clinical risk and ventricular function
Conclusions The high prevalence of CMD in both sexes suggests that it may be a useful target for future therapeutic interventions
Gender Tot pts CMD
Men 405 51%
Women 813 54% Regardless of sex:
Circulation. 2014;129:2518-2527
![Page 50: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/50.jpg)
…. there is now increasing evidence using both
SPECT and PET techniques, to suggest that a
‘‘warranty period’’ of 2 years (e.g., \2% risk of
death ? MI) following normal MPI may be extended
to [3 years or shortened to \1 year according to the
corresponding MFR results
deKemp et al Journal of Nuclear Cardiology July/August 2011
![Page 51: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/51.jpg)
STRESS TIME
O2
DEMAND
Chest pain Global dysfunction
Wall motion abnormality
Perfusion
heterogeneity
Ischemic Cascade
"The strenghts of MPI”
![Page 52: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/52.jpg)
Imaging and Ischemic Cascade
Majmudar MD, Nahrendorf M, J Nucl Med Vol. 53 • No. 5 • May 2012
![Page 53: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/53.jpg)
Oltre la Punta dell’Iceberg
PET: Quantizzazione assoluta MBF (ml/m)
Macro 2,5mm Micro <300mm
N Engl J Med. Feb. 2007; 356
•Funz. Endoteliale
• Microcircolo
• Ris. coronarica
• Circoli collaterali
![Page 54: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/54.jpg)
Tio RA et al., J Nucl Med 2009
CAD Patients
CAD Patients with Ischemia
Herzog BA et al., JACC 2009
Valore prognostico della Riserva di Flusso Coronarico PET
![Page 55: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/55.jpg)
A total of 7,061 patients from 4 centers underwent a clinically indicated rest/stress rubidium-82 PET MPI, with a median follow-up of 2.2 years. The primary outcome of this study was cardiac death (n 169), and the secondary outcome was all-cause death (n 570)
![Page 56: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/56.jpg)
Dorbala S et al. JACC Vol. 61, No. 2, 2013;
![Page 57: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/57.jpg)
Regadenoson PET
%
N=134 patients
Ali et at. J Nuc Med 2013
![Page 58: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/58.jpg)
The short duration of maximal hyperemia with regadenoson (2.3 min), combined with the short half-life of 82Rb (76s), are potential challenges to optimal regadenoson 82Rb imaging
….studies confirm that the hyperemic response of Regadenoson is comparable to that of dipyridamole during 82Rb MPI…..the clinical efficacy of Regadenoson as a vasodilator stress agent, when used with relative 82Rb MPI in a much larger cohort of patients, applying obstructive CAD on angiography as the gold standard.
J Nucl Med 2013;54:1748-1754
LVEF reserve is high in patients without significant ischemia or significant angiographic jeopardized myocardium
![Page 59: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/59.jpg)
** *
Coronary Blood Flow Regadenoson vs Adenosine in Awake Dogs
40
80
120
160
Baseline 0.1 500 10 1 100
Dose of agonist (µg/kg)
CBF
(ml/min)
***
***
***
***
***
***
Regadenoson
ED50 =0.34 ± 0.08 mg/kg
*** *** ***
***
Adenosine
ED50=51 ± 15 mg/kg
Δ = 150 fold
Trochu JN et al. J Cardiovasc Pharmacol 41:132-39, 2003
![Page 60: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/60.jpg)
R-R (ms) QT (ms) QTcF (ms)
Baseline 3 min Baseline 3 min Baseline 3 min
Regadenoson
(µg/kg)
2.5 699 ± 42 549 ± 50* 237 ± 6 223 ± 3* 268 ± 5 273 ± 5
5.0 701 ± 46 489 ± 23* 241 ± 5 217 ± 6* 272 ± 3 277 ± 6
10.0 675 ± 46 424 ± 17* 239 ± 9 212 ± 3* 273 ± 7 282 ± 7
Values are mean ± SEM, *) p<0.05, QTcF = QT/(R-R) 1/3
Modified from Gong Z. et al. JCP, 2008
Effects of Regadenoson on Heart Rate (R-R) and QT Interval
![Page 61: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/61.jpg)
82Rb PET Rest / Regadenoson
Scan Protocol
TID
J Nucl Med 2013;54:1748-1754
![Page 62: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/62.jpg)
Regadenoson LVEF reserve as function of Duke Jeopardy Score. LLK = low likelihood
J Nucl Med 2013;54:1748-1754
![Page 63: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/63.jpg)
Fusi
on
F
DG
-PET
T
rue
FISP
MR
I
courtesy Markus Schwaiger
![Page 64: Pesaro 13 Settembre 2014 Utilizzo in SPECT e PET › congressi › burroni... · 2014-09-22 · Utilizzo in SPECT e PET Pesaro 13 Settembre 2014 . Rapiscan agonista selettivo A 2A](https://reader034.vdocuments.site/reader034/viewer/2022042315/5f03324e7e708231d40803d6/html5/thumbnails/64.jpg)
Population 10 pts: Reversible ischemia at SPECT MPI
N-13 ammonia/ MR Gd - Regadenoson
Sens. 100% Spec 80% NPV 100%
This allows us to predict or rule out CAD with more certainty, and in some instances, it allows us to detect disease processes such as areas of hibernating heart muscle that would not have been detected using conventional stress testing methods like SPECT
Jeffrey M.C. Lau
SNMMI 2014: PET/MR for detecting Coronary Artery Disease